Search Results - Lavanya Sudharshan

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.

    48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis. by Dipen A Patel, Sonya J Snedecor, Wing Yu Tang, Lavanya Sudharshan, Jessica W Lim, Robert Cuffe, Sonia Pulgar, Kim A Gilchrist, Rodrigo Refoios Camejo, Jennifer Stephens, Garrett Nichols

    Published 2014-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: